Skip to main content

Table 1 Patient demographics

From: Integrating allele-specific PCR with CRISPR-Cas13a for sensitive KRAS mutation detection in pancreatic cancer

Patients

n = 24

Age

72.5 (51–89)

Sex

 Male

16 (66.7%)

 Female

8 (33.3%)

IMC (kg/m2)

25 (15–36)

ASA

 1

3 (12.5%)

 2

14 (58.3%)

 3

7 (29.2%)

Symptoms

 Pain

11 (45.8%)

 Jaundice

11 (45.8%)

 Altered General Condition

21 (87.5%)

 Unbalanced diabetes

3 (12.5%)

 Incidental

2 (8%)

Tumor localization

 Head

16 (66.8%)

 Body

5 (20.8%)

 Tail

2 (8.4%)

Suspected Diagnosis

 Ductal Adenocarcinoma

21 (87.5%)

 Degenerated IPMNs

1 (4.1%)

 Auto Immune

1 (4.1%)

 Ampulloma

1 (4.1%)

  1. ASA American Society of Anesthesiologists classification, IPMNs Intraductal Papillary Mucinous Neoplasms